Log in to save to my catalogue

Retraction: miR‐655 suppresses epithelial‐to‐mesenchymal transition by targeting Prrx1 in triple‐neg...

Retraction: miR‐655 suppresses epithelial‐to‐mesenchymal transition by targeting Prrx1 in triple‐neg...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11040458

Retraction: miR‐655 suppresses epithelial‐to‐mesenchymal transition by targeting Prrx1 in triple‐negative breast cancer

About this item

Full title

Retraction: miR‐655 suppresses epithelial‐to‐mesenchymal transition by targeting Prrx1 in triple‐negative breast cancer

Publisher

England: John Wiley & Sons, Inc

Journal title

Journal of cellular and molecular medicine, 2024-04, Vol.28 (8), p.e18314-n/a

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Zhi‐Dong Lv, Bin Kong, Xiang‐Ping Liu, Li‐Ying Jin, Qian Dong, Fu‐Nian Li, Hai‐Bo Wang, miR‐655 suppresses epithelial‐to‐mesenchymal transition by targeting Prrx1 in triple‐negative breast cancer. Journal of Cellular and Molecular Medicine, 20: 864–873. https://doi.org/10.1111/jcmm.12770<...